In addition, the administration of exogenous IL-22 in genetically obese leptin-receptor-deficient (db/db) mice and mice fed with HFD reverses many of the metabolic symptoms, including hyperglycemia and insulin resistance [49]. This evidence concerns the gene LEPR and Hyperglycemia.